Press Releases

GlobeNewswire, Inc.

BELVIDERE, NJ, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, better-for-you, sustainable...

GlobeNewswire, Inc.

TORONTO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the...

GlobeNewswire, Inc.

Revenue Grew 44% to $4.9 Million, Led by Continued Growth Across Cellular Therapy, Medical Testing, Laboratory and Aesthetics Beauty Services, and Healthcare Products Began Trading on the Nasdaq Global Market Under the Ticker Symbol "ALPS" in...

EIN Presswire

"Attract, Activate, Nurture, Amplify" guide shows CFIs how to deploy AI across the full consumer lifecycle, from first contact to lifelong loyalty SANTA CLARA, CA, UNITED STATES, August 7, 2026 /⁨EINPresswire.com⁩/ -- Eltropy, the agentic...

GlobeNewswire, Inc.

SUZHOU, China, Aug. 07, 2026 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions, today announced that it plans to report its financial results...

GlobeNewswire, Inc.

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will participate and host investor meetings at the following financial...

GlobeNewswire, Inc.

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co-founded by David Beckham,...

GlobeNewswire, Inc.

ASHBURN, Va., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to...

GlobeNewswire, Inc.

DURHAM, N.C., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company...

GlobeNewswire, Inc.

Net income grew 57% year-over-year to $715,697, with diluted EPS tripling to $0.003 Net cash provided by operating activities grew 108% to $707,131 All key operating subsidiaries profitable Repurchased and retired 3.7 million shares of common...

GlobeNewswire, Inc.

HUDSON, Mass. and YOKNEAM ILLIT, Israel, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and...

GlobeNewswire, Inc.

PONTE VEDRA, Fla., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related deformities,...

GlobeNewswire, Inc.

New preclinical data presented at European Association for Cancer Research (EACR) 2026 Annual Congress, which further validates the differentiated profile of IM1240's anti-tumor activity, favorable safety and pharmacokinetic profile, and broad...

GlobeNewswire, Inc.

Confirmatory Phase 3 trial of roluperidone (MIN-101C19) ongoing with topline efficacy data expected 2H 2027 Scientific Advisory Board of leading experts in psychiatry and neuroscience established to guide the confirmatory Phase 3 trial of...

GlobeNewswire, Inc.

Q2 2026 revenue of $29.1 million; GAAP basic EPS: $(0.12) Full year 2026 revenue guidance of $100.5 to $111.0 million affirmed NDA for F351 (hydronidone) for CHB-induced liver fibrosis accepted by China’s CDE in May 2026 SAN DIEGO, Aug. 07, 2026...

GlobeNewswire, Inc.

Reports second quarter 2026 total revenue of $8.1 million, representing 11% growth compared to the second quarter of 2025 Achieved a significant milestone with the 200th Growth Direct system placed globally; placed four Growth Direct systems and...

GlobeNewswire, Inc.

Quarterly net revenues of $266.0 million, an increase of 25.9% year-over-year Purified Cortrophin® Gel net revenues of $117.1 million, an increase of 43.5% year-over-year Quarterly GAAP net income available to common shareholders of $24.7 million;...

GlobeNewswire, Inc.

ATLANTA, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Gray Media (NYSE: GTN) today announced its financial results for the quarter ended June 30, 2026. EXECUTIVE COMMENTARY Hilton Howell, Jr., Executive Chairman and CEO, commented, “Our second quarter 2026...

GlobeNewswire, Inc.

PARSIPPANY, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported third quarter...

GlobeNewswire, Inc.

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coastal Financial Corp. (NASDAQ:CCB) for potential securities fraud after its significant stock drop.